PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
Holders of 5% or more of PMCB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of PharmaCyte Biotech, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 13G/A | 9.90%774.1K shares | – | Feb 13, 20251 filing | Feb 13, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on PharmaCyte Biotech, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 20264:47 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 4.99%532.3K shares | −5.00 ppfrom 9.99%Below 5% | Dec 31, 2025 | SEC |
| Nov 7, 20255:29 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.99%695.7K shares | 0.00 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Feb 13, 20251:42 PM ET | Ayrton Capital LLCand 2 others | 13G/A | 9.90%774.1K shares | – | Dec 31, 2024 | SEC |
| Jan 15, 20254:03 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 9.99%714.8K shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell PharmaCyte Biotech, Inc. shares.
No Form 144 notices for PharmaCyte Biotech, Inc. are on file.